Sean F. Moran Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

CRBP Quotes by TradingView

Sean F. Moran is Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 73,313 shares of CRBP, which is worth approximately $553,513. The most recent transaction as insider was on Feb 14, 2025, when has been sold 2,792 shares (Common Stock, par value $0.0001 per share) at a price of $8.76 per share, resulting in proceeds of $24,457. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.3K
50.83% 3M change
56.59% 12M change
Total Value Held $553,513

Sean F. Moran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
SELL
Open market or private sale
$24,457 $8.76 p/Share
2,792 Reduced 3.67%
73,313 Common Stock, par valu...
Jan 31 2025
BUY
Grant, award, or other acquisition
-
27,500 Added 26.54%
76,105 Common Stock, par valu...
Jun 18 2024
SELL
Open market or private sale
$82,470 $42.12 p/Share
1,958 Reduced 3.87%
48,605 Common Stock, par valu...
Jun 18 2024
BUY
Exercise of conversion of derivative security
$58,740 $30.0 p/Share
1,958 Added 3.73%
50,563 Common Stock, par valu...
Jun 17 2024
SELL
Open market or private sale
$314,762 $46.77 p/Share
6,730 Reduced 12.16%
48,605 Common Stock, par valu...
Jun 17 2024
BUY
Exercise of conversion of derivative security
$94,893 $14.1 p/Share
6,730 Added 10.84%
55,335 Common Stock, par valu...
Jun 14 2024
SELL
Open market or private sale
$466,533 $49.87 p/Share
9,355 Reduced 16.14%
48,605 Common Stock, par valu...
Jun 14 2024
BUY
Exercise of conversion of derivative security
$160,251 $17.13 p/Share
9,355 Added 14.23%
56,393 Common Stock, par valu...
Apr 10 2024
BUY
Exercise of conversion of derivative security
$53,610 $30.0 p/Share
1,787 Added 3.55%
48,605 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
40,176 Added 46.18%
46,818 Common Stock, par valu...
Aug 10 2022
BUY
Open market or private purchase
$5,200 $0.26 p/Share
20,000 Added 9.12%
199,272 Common Stock
May 16 2022
BUY
Open market or private purchase
$3,600 $0.3 p/Share
12,000 Added 6.27%
179,272 Common Stock
Mar 10 2022
BUY
Open market or private purchase
$5,550 $0.37 p/Share
15,000 Added 8.23%
167,272 Common Stock
Dec 21 2020
SELL
Open market or private sale
$153,125 $1.75 p/Share
87,500 Reduced 20.02%
349,610 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$122,500 $1.4 p/Share
87,500 Added 16.68%
437,110 Common Stock
Dec 18 2020
SELL
Open market or private sale
$75,054 $1.4 p/Share
53,610 Reduced 13.3%
349,610 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$53,610 $1.0 p/Share
53,610 Added 11.74%
403,220 Common Stock
Dec 16 2020
SELL
Open market or private sale
$48,738 $1.32 p/Share
36,923 Reduced 9.55%
349,610 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$6,277 $0.17 p/Share
36,923 Added 8.72%
386,533 Common Stock
SFM

Sean F. Moran

Chief Financial Officer
Norwood, MA

Track Institutional and Insider Activities on CRBP

Follow Corbus Pharmaceuticals Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBP shares.

Notify only if

Insider Trading

Get notified when an Corbus Pharmaceuticals Holdings, Inc. insider buys or sells CRBP shares.

Notify only if

News

Receive news related to Corbus Pharmaceuticals Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRBP